(The article featured
below is a selection from Federal
Securities Law Reporter, which is available to subscribers of that
publication.)
Staff Reverses Position on Livestock Antibiotics
Proposals
The SEC’s Division of Corporation Finance has reversed its
earlier view that Tyson Foods, Inc. may omit a shareholder proposal relating to
the use of antibiotics in raising livestock. The staff initially advised that
Tyson could omit the proposal from its proxy materials in reliance on the
ordinary business exclusion. However, after reconsideration, the staff concluded
that the widespread public debate about antimicrobial resistance and the use of
antibiotics in raising livestock raises significant policy issues and cannot be
considered part of a meat producer’s ordinary business operations.
The shareholder proposal was submitted by Trinity Health and the
Adrian Dominican Sisters for consideration at Tyson’s 2010 meeting of
shareholders. Tyson asked the SEC to concur that the proposal could be omitted
under Rule 14a-8(i)(7) because it related to ordinary business operations.
The proponents sought reconsideration of the staff’s decision
based on their belief that the staff had failed to recognize the significant
policy issue presented by their proposal. In their view, the staff failed to see
the larger public health issue and instead focused on the choice of production
methods.
The proponents repeated their previously submitted evidence to
support the view that the use of antibiotics in raising livestock raises
significant policy issues, including scientific studies, calls for reform by the
Food and Drug Administration and other respected organizations, and the ban on
the use of nontherapeutic antimicrobials in the European Union. The proponents
included new data on media coverage about the issue.
Tyson asked the staff to deny the proponents’ request for
reconsideration by arguing that they failed to raise any additional substantive
issues. Tyson said that it is actively working with producers and industry trade
groups to ensure that its antibiotic use is properly managed. Tyson’s hog
production operations use only antibiotics that have been approved by the FDA
and they are administered by a licensed veterinarian in compliance with FDA
protocols, according to its counsel.
Tyson said the proposal was excludable because it relates to
ordinary business activities, interferes with management’s ability to run the
day-to-day operations and would allow the shareholders to micromanage the
company. Tyson also argued that the proposal did not involve a matter of
substantial importance and that it was neither novel nor complex, standards
which the staff applies in requests for Commission review.
The staff noted that two no-action responses in 2002 and 2003
permitted companies to rely on Rule 14a-8(i)(7) to exclude comparable proposals
relating to the use of antibiotics in livestock production, but said those
positions should now be reversed. In reaching this decision, the staff referred
to the European Union’s ban on the use of most antibiotics as feed additives
and the introduction by Congress of legislation to prohibit the nontherapeutic
use of antibiotics in animals absent certain safety findings.
In reaching its initial decision, the staff did not address an
alternative basis for exclusion of the proposal upon which Tyson wished to rely.
Tyson believed the proposal could be excluded under Rule 14a-8(i)(11) because of
the submission of identical proposals by the two proponents. The staff noted
that Tyson received one of the proposals before the other, but Trinity Health
intends to cosponsor the proposal submitted by the Adrian Dominican Sisters.
Accordingly, the proposal may not be excluded under Rule 14a-8(i)(11).
□ Tyson Foods, Inc. (Adrian Dominican Sisters) (SEC)
and Tyson Foods, Inc. (Trinity Health) (Recon.) (SEC) will be published
in a forthcoming Report.
|